{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:25:57Z","timestamp":1781731557614,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1084951"],"award-info":[{"award-number":["APP1084951"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1135959"],"award-info":[{"award-number":["APP1135959"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1110891"],"award-info":[{"award-number":["APP1110891"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jinf.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:18:32Z","timestamp":1544055512000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program"],"prefix":"10.1016","volume":"78","author":[{"given":"Helen E.","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather F.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Booy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine K.","family":"Macartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.11.009_bib0001","first-page":"544","article-title":"Varicella vaccination in Australia","volume":"41","author":"Macartney","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2018.11.009_bib0002","year":"2013","journal-title":"Significant events in varicella vaccination practice in Australia"},{"key":"10.1016\/j.jinf.2018.11.009_bib0003","doi-asserted-by":"crossref","first-page":"156","DOI":"10.33321\/cdi.2013.37.22","article-title":"Adolescent school-based vaccination in Australia","volume":"37","author":"Ward","year":"2013","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.jinf.2018.11.009_bib0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5694\/j.1326-5377.2005.tb06555.x","article-title":"Varicella seroprevalence and vaccine uptake in preschool children","volume":"182","author":"Gilbert","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.jinf.2018.11.009_bib0005","series-title":"Annual immunisation coverage report","author":"Hull","year":"2016"},{"key":"10.1016\/j.jinf.2018.11.009_bib0006","series-title":"The Australian immunisation handbook","year":"2013"},{"key":"10.1016\/j.jinf.2018.11.009_bib0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/archdischild-2015-308468","article-title":"Encephalitis in Australian children: contemporary trends in hospitalisation","volume":"101","author":"Britton","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jinf.2018.11.009_bib0008","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2471\/BLT.13.132142","article-title":"Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study","volume":"92","author":"Heywood","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jinf.2018.11.009_bib0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/adc.2010.206037","article-title":"Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia","volume":"96","author":"Khandaker","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jinf.2018.11.009_bib0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/INF.0b013e31827e92b7","article-title":"Changes in patterns of hospitalised varicella in children and associated varicella genotypes following introduction of varicella vaccine in Australia","volume":"32","author":"Marshall","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2018.11.009_bib0011","article-title":"80 students struck down with chickenpox in Brunswick school outbreak","author":"Smith","year":"2015","journal-title":"Kidspot"},{"key":"10.1016\/j.jinf.2018.11.009_bib0012","first-page":"E48","article-title":"Australia's notifiable disease status","volume":"40","author":"NNDSS Annual Report Working Group","year":"2016"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2018.11.009_bib0013","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2013United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.11.009_bib0014","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2018.11.009_bib0015","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2007.07.010","article-title":"Metaanalysis of vaccine effectiveness in varicella outbreaks","volume":"25","author":"Bayer","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2018.11.009_bib0016","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.jinf.2018.11.009_bib0017","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","article-title":"Efficacy of high-titer live attenuated varicella vaccine in healthy young children","volume":"174","author":"Varis","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.11.009_bib0018","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella virus vaccine. Efficacy trial in healthy children","volume":"31","author":"Weibel","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2018.11.009_bib0019","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"Morb Mortal Wkly Rep, Recommendations & Reports"},{"key":"10.1016\/j.jinf.2018.11.009_bib0020","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain","volume":"9","author":"Cenoz","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2018.11.009_bib0021","first-page":"415","article-title":"Preventing varicella: recommendations for routine two-dose varicella immunization in children","volume":"16","author":"Salvadori","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2018.11.009_bib0022","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2016.02.040","article-title":"Strong additional effect of a second varicella vaccine dose in children in Germany, 2009\u20132014","volume":"173","author":"Siedler","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2018.11.009_bib0023","year":"2007","journal-title":"Public summary document \u2013 measles, mumps, rubella and varicella vaccine, powder for injection with diluent syringe, 0.5 mL, Priorix-Tetra\u00a9"},{"key":"10.1016\/j.jinf.2018.11.009_bib0024","series-title":"The Australian immunisation handbook","year":"2008"},{"key":"10.1016\/j.jinf.2018.11.009_bib0025","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.33321\/cdi.2016.40.42","article-title":"Paediatric Active Enhanced Disease Surveillance (PAEDS) inaugural report 2014: prospective hospital-based surveillance for select vaccine preventable diseases and adverse events following immunisation","volume":"40","author":"Zurynski","year":"2016","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.jinf.2018.11.009_bib0026","article-title":"Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program","author":"Marshall","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.11.009_bib0027","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1016\/j.vaccine.2009.06.056","article-title":"The Australian childhood immunisation register \u2013 a model for universal immunisation registers","volume":"27","author":"Hull","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2018.11.009_bib0028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5365\/wpsar.2015.6.2.007","article-title":"An assessment of measles vaccine effectiveness, Australia, 2006\u20132012","volume":"6","author":"Pillsbury","year":"2015","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/j.jinf.2018.11.009_bib0029","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1542\/peds.2013-3181","article-title":"Duration of protection after first dose of acellular pertussis vaccine in infants","volume":"133","author":"Quinn","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2018.11.009_bib0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/oxfordjournals.epirev.a036023","article-title":"Assessing vaccine efficacy in the field. Further observations","volume":"10","author":"Orenstein","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jinf.2018.11.009_bib0031","year":"2014","journal-title":"3238.0 \u2013 Estimates and projections, aboriginal and Torres Strait Islander Australians, 2001 to 2026. Canberra: Australian Government"},{"key":"10.1016\/j.jinf.2018.11.009_bib0032","doi-asserted-by":"crossref","first-page":"pii:20926","DOI":"10.2807\/1560-7917.ES2014.19.41.20926","article-title":"Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012","volume":"19","author":"Kelly","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jinf.2018.11.009_bib0033","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5694\/j.1326-5377.2010.tb03818.x","article-title":"Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine","volume":"193","author":"Nelson","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.jinf.2018.11.009_bib0034","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.vaccine.2017.05.013","article-title":"Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia","volume":"35","author":"Sheridan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2018.11.009_bib0035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2018.11.009_bib0036","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres","volume":"28","author":"Spackova","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2018.11.009_bib0037","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2018.11.009_bib0038","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2018.11.009_bib0039","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.11.009_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S0950268809990860","article-title":"Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia","volume":"138","author":"Gao","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2018.11.009_bib0041","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(14)60078-7","article-title":"Prevention of varicella: time for two-dose vaccination","volume":"383","author":"Macartney","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2018.11.009_bib0042","first-page":"1","article-title":"Centers for Disease Control and Prevention, Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"Morbid Mortal Wkly Rep, Recommendations & Reports"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531830358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344531830358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:27:23Z","timestamp":1759008443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344531830358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S016344531830358X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.11.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}